✦ New CED Clinical Relevance #86High Clinical Relevance Strong evidence or policy relevance with direct clinical implications. ⚒ Cannabis News | CED Clinic Harm ReductionDelivery MethodsPulmonary HealthNeurodegenerationInflammation Why This MattersUnderstanding the lung-brain axis in smoking-related neurodegeneration...
The effects of chronic cannabidiol administration on brain pathology and behavioral deficits found in the tau P301s-line PS19 mouse model of Alzheimer’s disease.
BackgroundCompounds derived from the plant
The role of cannabinoid ligands in neurodegenerative diseases: emerging anti-inflammatory, immunomodulation and disease-modifying perspectives.
Neurodegenerative diseases (NDs) constitute a growing global health burden driven by population aging and remain without disease-modifying therapies. Althoug…
Fecal transplants ease motor symptoms in early Parkinson’s: Study
✦ New CED Clinical Relevance #80High Clinical Relevance Strong evidence or policy relevance with direct clinical implications. ⚒ Cannabis News | CED Clinic Parkinson'S DiseaseMicrobiomeNeurodegenerationGut-Brain AxisMotor Symptoms Why This MattersThis emerging research connects gut microbiome dysbiosis...
Alzheimer’s | Center for Medical Cannabis | Utah Department of Health and Human Services
✦ New CED Clinical Relevance #76Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic Alzheimer'SNeurodegenerationState PolicyClinical GuidelinesBehavioral Symptoms Why This MattersUtah's evidence-based guidelines represent one of the first...
Smoking weed and tobacco shrinks your brain – The Times of India
✦ New CED Clinical Relevance #75 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. ResearchNeurologySafetyMental Health Why This Matters Clinicians should counsel patients that concurrent cannabis and tobacco use...
Cell therapy eases Parkinson’s motor symptoms in early trial
✦ New CED Clinical Relevance #80High Clinical Relevance Strong evidence or policy relevance with direct clinical implications. ⚒ Cannabis News | CED Clinic Parkinson'S DiseaseCell TherapyNeurodegenerationMotor SymptomsClinical Trials Why This MattersEarly-stage cell therapy trials in Parkinson's...
Variations in p21 protein may explain why some MS types progress faster
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic Multiple SclerosisBiomarkersNeurodegenerationPersonalized MedicineDisease Progression Why This MattersUnderstanding protein variations that drive MS progression could...
When it comes to Parkinson’s, hope is not a plan, but urgent action is
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic Parkinson'S DiseaseNeurodegenerationPatient ExpectationsEvidence-Based MedicineChronic Disease Management Why This MattersParkinson's disease affects over 1 million...
Activation of a cannabinoid receptor represents a promising therapeutic strategy for Parkinson’s Disease
Activation of CB2R with AM1241 ameliorates neurodegeneration via the Xist/miR-133b-3p/Pitx3 axis In Summary Schematic representation showing the proposed mechanism by which the CBR2 agonist AM1241 exerts neuroprotective effects through the Xist/ miR-133b-3p/Pitx3...